First-in-human studies anticipated to begin in 2026Engaged a top tier U.S. based contract manufacturer to ensure the highest standards of ...

Entyvio’s dosage is an intravenous (IV) infusion every 8 weeks or a subcutaneous injection every 2 weeks. The starting dosage is two infusions 2 weeks apart. After that, you’ll continue with ...

Subcutaneous immunotherapy injections for cancer, such as immune checkpoint inhibitors, are an emerging therapy that may replace some traditional intravenous infusions. Common side effects include ...